Quetiapine Efficacy in Bipolar Depression Study

A 8-Week, Multicenter, Open-Label, Observational Study of the Efficacy of Quetiapine Fumarate (SEROQUEL) Immediate-Release Tablets in Adult Patients With Bipolar Depression

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00523601

Acronym

QUEEN

Enrollment

2000

Registered

2007-08-31

Start date

2007-06-30

Completion date

2007-12-31

Last updated

2008-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Depression

Keywords

Bipolar depression, quetiapine, observational, Naturalistic

Brief summary

To reassure the clinical study data on Seroquel antidepressant efficacy in patients who are diagnosed as bipolar depression

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* The patient and the patient's legal representative (if any) must understand the nature of the study and must have given written consent * Meet DSM-IV-TR criteria for bipolar depression at the time of baseline

Exclusion criteria

* Since this programme intends to describe quetiapine use in routine clinical practice when prescribed as treatment of bipolar depression, there are no programme specific

Countries

South Korea

Outcome results